Signet Financial Management’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-23,032
Closed -$1.6M 271
2023
Q3
$1.6M Buy
23,032
+38
+0.2% +$2.87K 0.26% 119
2023
Q2
$1.86M Buy
22,994
+253
+1% +$20.7K 0.29% 104
2023
Q1
$1.84M Buy
22,741
+295
+1% +$23.7K 0.31% 100
2022
Q4
$1.68M Sell
22,446
-125
-0.6% -$8.9K 0.3% 101
2022
Q3
$1.46M Buy
22,571
+226
+1% +$15.7K 0.28% 97
2022
Q2
$1.55M Sell
22,345
-1,667
-7% -$124K 0.3% 97
2022
Q1
$1.84M Buy
24,012
+529
+2% +$38K 0.31% 91
2021
Q4
$1.8M Buy
23,483
+10
+0% +$735 0.27% 94
2021
Q3
$1.73M Buy
+23,473
New +$1.76M 0.3% 90
2021
Q2
Sell
-2,721
Closed -$202K 161
2021
Q1
$202K Buy
+2,721
New +$207K 0.04% 229

Other funds holding HOLX

Signet Financial Management's HOLX Position: Q4 2023 in Review

Signet Financial Management sold out of Hologic (HOLX) in Q4 2023, closing a stake of 23,032 shares — an estimated $1.6M sold.

Signet Financial Management first reported a position in HOLX in Q1 2021 and held it in 10 quarters. The position peaked at $1.86M in Q2 2023. 733 funds tracked by Wall St. Rank hold HOLX as of Q4 2023.

  • Signet Financial Management reported no remaining Hologic position as of Q4 2023 after selling out during the quarter.
  • Signet Financial Management sold 23,032 Hologic shares in Q4 2023, an estimated $1.6M.
  • Signet Financial Management first reported a position in Hologic in Q1 2021 and held it in 10 quarters.
  • Signet Financial Management's Hologic position peaked at $1.86M in Q2 2023.
  • 733 funds tracked by Wall St. Rank held Hologic as of Q4 2023.

Based on Signet Financial Management's 13F filing for Q4 2023, filed 30 Jan 2024.